Device Firms Would Have To Report Sales Prices To CMS Under Senate Bill
This article was originally published in The Gray Sheet
Executive Summary
A bill introduced Oct. 23 in the Senate would require device makers seeking Medicare reimbursement to report to CMS the prices they negotiate with hospitals and other buyers for all implantable medical devices
You may also be interested in...
Devices Account For 6.2% Of Health Expenditures, AdvaMed Study Finds
As congressional reformers look for ways to cut health care costs, AdvaMed aims to raise awareness that medical devices and diagnostics represent only a single-digit share of national health care expenditures
Devices Account For 6.2% Of Health Expenditures, AdvaMed Study Finds
As congressional reformers look for ways to cut health care costs, AdvaMed aims to raise awareness that medical devices and diagnostics represent only a single-digit share of national health care expenditures
Mandatory Disclosure Of Device Pricing Would Raise Costs – Industry Study
A pending Senate bill that calls for mandatory disclosure of prices paid by hospitals for implantable medical devices would most likely lead to higher prices, contrary to its original intent, according to a 1study released Feb. 19